As Sage Therapeutics (SAGE) Share Price Declined, Palo Alto Investors Has Raised Stake; Northern Trust (NTRS) Holder Gofen & Glossberg Has Cut Holding by $452,925

April 26, 2018 - By Jacob Smith

Northern Trust Corporation (NASDAQ:NTRS) Logo

Gofen & Glossberg Llc decreased its stake in Northern Trust (NTRS) by 2.88% based on its latest 2017Q4 regulatory filing with the SEC. Gofen & Glossberg Llc sold 4,575 shares as the company’s stock rose 2.63% while stock markets declined. The institutional investor held 154,229 shares of the major banks company at the end of 2017Q4, valued at $15.41 million, down from 158,804 at the end of the previous reported quarter. Gofen & Glossberg Llc who had been investing in Northern Trust for a number of months, seems to be less bullish one the $24.17 billion market cap company. The stock increased 0.56% or $0.6 during the last trading session, reaching $107.43. About 1.00M shares traded. Northern Trust Corporation (NASDAQ:NTRS) has risen 19.41% since April 26, 2017 and is uptrending. It has outperformed by 7.86% the S&P500.

William Leland Edwards increased its stake in Sage Therapeutics Inc (SAGE) by 2.99% based on its latest 2017Q4 regulatory filing with the SEC. Palo Alto Investors Llc bought 23,555 shares as the company’s stock declined 6.84% with the market. The hedge fund run by William Leland Edwards held 810,806 shares of the health care company at the end of 2017Q4, valued at $133.55 million, up from 787,251 at the end of the previous reported quarter. Palo Alto Investors Llc who had been investing in Sage Therapeutics Inc for a number of months, seems to be bullish on the $6.58 billion market cap company. The stock increased 2.35% or $3.3 during the last trading session, reaching $143.66. About 296,056 shares traded. Sage Therapeutics, Inc. (NASDAQ:SAGE) has risen 135.95% since April 26, 2017 and is uptrending. It has outperformed by 124.40% the S&P500.

Since January 26, 2018, it had 0 insider buys, and 16 sales for $21.55 million activity. BROWNE ROBERT P sold $640,740 worth of stock. The insider Parker Teresa sold $1.07 million. On Friday, February 16 MORRISON WILLIAM L sold $2.10 million worth of Northern Trust Corporation (NASDAQ:NTRS) or 20,000 shares. Another trade for 30,917 shares valued at $3.26M was made by Cohodes Jeffrey D. on Friday, January 26. Bowman Biff sold $1.50 million worth of stock or 13,811 shares. $749,722 worth of Northern Trust Corporation (NASDAQ:NTRS) shares were sold by Potter Stephen N.

Gofen & Glossberg Llc, which manages about $3.51 billion and $2.80 billion US Long portfolio, upped its stake in Merck (NYSE:MRK) by 11,028 shares to 385,367 shares, valued at $21.69M in 2017Q4, according to the filing. It also increased its holding in Intel (NASDAQ:INTC) by 8,391 shares in the quarter, for a total of 159,997 shares, and has risen its stake in Athene Holding Ltd Cl A.

Investors sentiment increased to 1.03 in 2017 Q4. Its up 0.06, from 0.97 in 2017Q3. It increased, as 27 investors sold NTRS shares while 191 reduced holdings. 59 funds opened positions while 165 raised stakes. 175.58 million shares or 4.39% less from 183.65 million shares in 2017Q3 were reported. Ftb holds 303 shares. Federated Invsts Incorporated Pa stated it has 0.09% in Northern Trust Corporation (NASDAQ:NTRS). Tributary Capital Management Ltd Company owns 0.22% invested in Northern Trust Corporation (NASDAQ:NTRS) for 25,850 shares. Calamos Advsrs Ltd stated it has 0.01% in Northern Trust Corporation (NASDAQ:NTRS). Fdx Advsrs Inc holds 10,160 shares or 0.03% of its portfolio. The Minnesota-based Speece Thorson Grp Inc has invested 3.07% in Northern Trust Corporation (NASDAQ:NTRS). 2.87M are held by Primecap Mgmt Co Ca. Benjamin F Edwards stated it has 202 shares. Quantitative Investment Limited Co has invested 0.11% in Northern Trust Corporation (NASDAQ:NTRS). Amg Funds Ltd Com reported 16,788 shares. First City Cap holds 12,023 shares. Old Second Bancorporation Of Aurora reported 300 shares. Dalton Greiner Hartman Maher & Co accumulated 0.02% or 4,467 shares. Thrivent Fincl For Lutherans owns 11,449 shares for 0% of their portfolio. Farmers & Merchants reported 0.03% of its portfolio in Northern Trust Corporation (NASDAQ:NTRS).

Among 17 analysts covering Northern Trust Corporation (NASDAQ:NTRS), 7 have Buy rating, 1 Sell and 9 Hold. Therefore 41% are positive. Northern Trust Corporation had 75 analyst reports since August 6, 2015 according to SRatingsIntel. Sandler O’Neill maintained Northern Trust Corporation (NASDAQ:NTRS) on Tuesday, January 9 with “Hold” rating. Deutsche Bank maintained it with “Hold” rating and $72.0 target in Friday, January 8 report. Deutsche Bank maintained the stock with “Hold” rating in Thursday, July 20 report. The rating was maintained by Morgan Stanley with “Underweight” on Thursday, July 20. As per Tuesday, September 26, the company rating was maintained by RBC Capital Markets. Keefe Bruyette & Woods maintained it with “Hold” rating and $10800 target in Wednesday, April 4 report. The firm has “Hold” rating given on Monday, July 11 by Jefferies. As per Friday, May 26, the company rating was maintained by Keefe Bruyette & Woods. Jefferies maintained Northern Trust Corporation (NASDAQ:NTRS) rating on Wednesday, October 18. Jefferies has “Buy” rating and $111.0 target. The firm has “Hold” rating by Keefe Bruyette & Woods given on Tuesday, December 12.

Among 18 analysts covering SAGE Therapeutics (NASDAQ:SAGE), 16 have Buy rating, 0 Sell and 2 Hold. Therefore 89% are positive. SAGE Therapeutics had 57 analyst reports since September 3, 2015 according to SRatingsIntel. The stock of Sage Therapeutics, Inc. (NASDAQ:SAGE) earned “Buy” rating by SunTrust on Thursday, December 7. Lake Street initiated Sage Therapeutics, Inc. (NASDAQ:SAGE) on Friday, March 11 with “Buy” rating. On Thursday, December 7 the stock rating was maintained by Stifel Nicolaus with “Buy”. Leerink Swann maintained the shares of SAGE in report on Thursday, December 7 with “Buy” rating. Canaccord Genuity maintained the shares of SAGE in report on Monday, November 13 with “Buy” rating. On Tuesday, September 12 the stock rating was maintained by Cowen & Co with “Buy”. On Wednesday, June 29 the stock rating was initiated by BMO Capital Markets with “Outperform”. On Tuesday, February 27 the stock rating was maintained by SunTrust with “Buy”. The rating was maintained by RBC Capital Markets with “Buy” on Thursday, November 2. Canaccord Genuity maintained it with “Buy” rating and $81.0 target in Tuesday, September 12 report.

Palo Alto Investors Llc, which manages about $1.30 billion and $2.32B US Long portfolio, decreased its stake in Exact Sciences Corp (NASDAQ:EXAS) by 122,200 shares to 310,876 shares, valued at $16.33 million in 2017Q4, according to the filing. It also reduced its holding in Align Technology Inc (NASDAQ:ALGN) by 10,600 shares in the quarter, leaving it with 212,507 shares, and cut its stake in Amicus Therapeutics Inc (NASDAQ:FOLD).

Investors sentiment increased to 1.49 in 2017 Q4. Its up 0.28, from 1.21 in 2017Q3. It is positive, as 27 investors sold SAGE shares while 56 reduced holdings. 63 funds opened positions while 61 raised stakes. 41.45 million shares or 7.53% more from 38.55 million shares in 2017Q3 were reported. Voya Management Ltd Liability Company owns 17,079 shares. Susquehanna Gru Limited Liability Partnership has invested 0.02% of its portfolio in Sage Therapeutics, Inc. (NASDAQ:SAGE). Goldman Sachs Gp Inc reported 224,819 shares. Cornerstone Mgmt Hldg Limited Company holds 0.02% of its portfolio in Sage Therapeutics, Inc. (NASDAQ:SAGE) for 15,038 shares. Element Capital Mngmt Ltd Liability Co invested 0.29% of its portfolio in Sage Therapeutics, Inc. (NASDAQ:SAGE). Moreover, Dubuque Retail Bank has 0.05% invested in Sage Therapeutics, Inc. (NASDAQ:SAGE) for 1,810 shares. Balyasny Asset Mgmt Ltd Liability Corp reported 0.13% of its portfolio in Sage Therapeutics, Inc. (NASDAQ:SAGE). Cibc Ww Mkts accumulated 4,430 shares. Kingdon Capital Mgmt Ltd Company reported 130,516 shares. Los Angeles Mgmt & Equity Research holds 3,100 shares or 0% of its portfolio. Westpac Banking holds 0.27% in Sage Therapeutics, Inc. (NASDAQ:SAGE) or 71,939 shares. Point72 Asset Management Limited Partnership holds 0.01% or 10,000 shares in its portfolio. Parametrica Mngmt Ltd holds 3,463 shares. Century holds 29,236 shares. The Illinois-based Nuveen Asset Llc has invested 0.01% in Sage Therapeutics, Inc. (NASDAQ:SAGE).

Sage Therapeutics, Inc. (NASDAQ:SAGE) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


>